Contact Us

DESTINATION NEWS

MSB and TerraPay Collaborate to Simplify and Enhance Cross-Border Money Transfers

Sep 19, 2024

HANOI,Vietnam,Sept. 19,2024-- Vietnam Maritime Commercial Joint Stock Bank (HoSE: MSB) has signed a strategic cooperation agreement with TerraPay,a global money movement company. This collaboration w

We left the UK and settled in Australia for a better family life - our children are so much happier here

Sep 18, 2024

British families have been uprooting their lives to move their children to Australia in order for them to have a 'better life' - and three sets of parents from the UK have shared their stories on social media.

Autoliv appoints Fabien Dumont as Executive Vice President & Chief Technology Officer

Sep 18, 2024

STOCKHOLM,Sept. 17,2024--- Autoliv,Inc. (NYSE: ALV) (SSE: ALIVsdb),the worldwide leader in automotive safety systems,appoints Fabien Dumont as Executive Vice President & Chief Technology Officer a

Zoetis to Introduce First Cartridge-Based AI-Powered Haematology Analyser

Sep 18, 2024

Zoetis is introducing Vetscan® OptiCellâ„¢ to Australia as it continues to transform diagnostics with its suite of integrated products and services

Metabolon Expands Integrated Bioinformatics Platform to Include Advanced Statistical Analysis Tool

Sep 18, 2024

New tool plays a critical role in supporting complex multiomic research initiatives by helping scientists design and execute customized statistical analyses

Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30 for Both Once-Monthly Subcutaneous Injection and Once-Daily Oral Tablet for the Treatment of Obesity

Sep 18, 2024

- ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R)agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity

1 ... 148 149 150 151 152 153 154 ... 232